Mulado (Metformin Hydrochloride)

Metformin, the active ingredient in Mulado, is a biguanide presented as an oral tablet for oral administration. It helps lower elevated blood glucose levels by reducing hepatic glucose production and improving insulin sensitivity, and is indicated for the long‑term management of type 2 diabetes mellitus in adult patients.

GNH USA supplies Mulado as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable, on‑time delivery to meet global healthcare needs.

Metformin is a biguanide antidiabetic that primarily targets glucose metabolism in type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired fasting glucose): helps delay progression to overt diabetes. - Polycystic ovary syndrome: reduces insulin resistance and may restore ovulatory cycles.

Metformin is generally well tolerated, but a range of adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, especially during treatment initiation. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration of taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycemia: usually when combined with insulin or sulfonylureas. - Hepatic failure: rare hepatic dysfunction. - Allergic reactions: rash, pruritus, or angioedema. - Metabolic acidosis: non‑lactic acid accumulation. - Pancreatitis: very uncommon inflammation of the pancreas.

Metformin requires careful assessment of patient factors before and during therapy.

- Renal function assessment: evaluate eGFR and avoid use in severe renal impairment. - Hepatic disease monitoring: use cautiously in patients with liver dysfunction. - Cardiovascular status: consider risk of lactic acidosis in unstable heart failure. - Concomitant alcohol intake: limit alcohol to reduce lactic acidosis risk. - Pregnancy and lactation: assess benefit‑risk ratio with obstetric guidance. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metformin may interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: risk of acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol excess: potentiates lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: monitor renal function and potassium levels. - Digoxin: may increase risk of hypoglycemia when combined with insulin.